We are live on ! Find out more
VCM

Versant Capital Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.66%
AUM
$1.01B
AUM Growth
+$217M
Cap. Flow
+$212M
Cap. Flow %
20.87%
Top 10 Hldgs %
33.44%
Holding
2,859
New
220
Increased
1,610
Reduced
469
Closed
82

Sector Composition

Rank Sector Weight
1 Technology 17.87%
2 Financials 6.8%
3 Industrials 6.1%
4 Consumer Discretionary 4.96%
5 Healthcare 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VONV icon
1926
Vanguard Russell 1000 Value ETF
VONV
$22B
$15.9K ﹤0.01%
170
RDVY icon
1927
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
$15.9K ﹤0.01%
233
DAWN
1928
DELISTED
Day One Biopharmaceuticals
DAWN
$15.9K ﹤0.01%
742
+138
+23% +$1.95K
IIIV icon
1929
i3 Verticals
IIIV
$336M
$15.9K ﹤0.01%
711
+442
+164% +$10.3K
MPT
1930
Medical Properties Trust
MPT
$2.46B
$15.9K ﹤0.01%
3,424
FIDU icon
1931
Fidelity MSCI Industrials Index ETF
FIDU
$2.38B
$15.8K ﹤0.01%
183
-250
-58% -$22.5K
SILJ icon
1932
Amplify Junior Silver Miners ETF
SILJ
$3.92B
$15.8K ﹤0.01%
+532
New +$17.6K
ITOT icon
1933
iShares Core S&P Total US Stock Market ETF
ITOT
$97.7B
$15.8K ﹤0.01%
111
BWB icon
1934
Bridgewater Bancshares
BWB
$596M
$15.8K ﹤0.01%
891
+20
+2% +$367
SMMT icon
1935
Summit Therapeutics
SMMT
$11.6B
$15.8K ﹤0.01%
831
+821
+8,210% +$13.3K
ALTG icon
1936
Alta Equipment Group
ALTG
$234M
$15.7K ﹤0.01%
2,926
+701
+32% +$4.45K
DYN icon
1937
Dyne Therapeutics
DYN
$4.95B
$15.6K ﹤0.01%
859
UBSI icon
1938
United Bankshares
UBSI
$6.54B
$15.6K ﹤0.01%
376
+52
+16% +$2.16K
OUST icon
1939
Ouster
OUST
$2.86B
$15.6K ﹤0.01%
847
+214
+34% +$4.66K
AGNC icon
1940
AGNC Investment
AGNC
$12.7B
$15.6K ﹤0.01%
1,551
+879
+131% +$9.72K
KD icon
1941
Kyndryl
KD
$2.98B
$15.5K ﹤0.01%
1,185
+773
+188% +$13.6K
HRI icon
1942
Herc Holdings
HRI
$5.64B
$15.5K ﹤0.01%
156
+151
+3,020% +$21.5K
WEAV icon
1943
Weave Communications
WEAV
$434M
$15.5K ﹤0.01%
3,359
+2,965
+753% +$17.3K
ARES icon
1944
Ares Management
ARES
$30.5B
$15.5K ﹤0.01%
142
-606
-81% -$80.4K
ATEX icon
1945
Anterix
ATEX
$1.79B
$15.5K ﹤0.01%
+405
New +$12.8K
VRTS icon
1946
Virtus Investment Partners
VRTS
$1.11B
$15.4K ﹤0.01%
115
+101
+721% +$14.9K
PULS icon
1947
PGIM Ultra Short Bond ETF
PULS
$18.4B
$15.4K ﹤0.01%
311
AVAV icon
1948
AeroVironment
AVAV
$9.46B
$15.4K ﹤0.01%
84
+4
+5% +$1.05K
KAI icon
1949
Kadant
KAI
$3.88B
$15.2K ﹤0.01%
52
+41
+373% +$13.2K
STAG icon
1950
STAG Industrial
STAG
$7.08B
$15.2K ﹤0.01%
421

Similar funds

Versant Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Versant Capital Management held 2,859 positions worth $1.01B, up 27% from $797M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Versant Capital Management deployed $212M of net new capital in Q1 2026, opening 220 new positions and adding to 1,610 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $1.27M trimmed.

  • Versant Capital Management's largest Q1 2026 buy was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
  • Versant Capital Management added most to Microsoft in Q1 2026, an estimated $57.7M increase.
  • Versant Capital Management's biggest Q1 2026 reduction was VanEck Gold Miners ETF, cutting an estimated $1.27M.
  • Versant Capital Management fully exited AstraZeneca in Q1 2026, selling an estimated $1.1M.
  • Versant Capital Management's ten largest holdings make up 33% of its $1.01B portfolio in Q1 2026.
  • Versant Capital Management opened 220 new positions and closed 82 in Q1 2026.
  • Versant Capital Management's portfolio value rose 27% quarter-over-quarter to $1.01B.

Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.